Skip to content

Deciphering the Molecular Mechanisms of Apigenin in Neurodegenerative Diseases Through Network Pharmacology, Molecular Docking, and DFT Analysis

Sep 2026 · Journal of Pharmaceutical Innovation · Vol 22 · 0 citations · 30 references

TL;DR

Its favorable binding characteristics, electronic stability, and predicted brain permeability highlight apigenin as a potential candidate for the prevention and treatment of neurodegenerative diseases, warranting further experimental and clinical validation.

View source

Similar papers

Open access 2026

Neuroprotective role of hydroxychloroquine and trimebutine in alzheimer’s disease: Network pharmacology and molecular simulations

An integrated in silico approach consisting of network pharmacology, molecular docking, molecular dynamics simulation, gene expression profiling using AlzData and cell permeability analysis was used to evaluate the therapeutic efficacy of Trimebutine and Hydroxychloroquine against Alzheimer's disease, establishing stab...

Renukaradhya Maharudraiah, K. Kant, Madhusudhan Reddy Alimeneti et al. · 0 citations
Open access Sep 2026

Multi-Target Neuroprotective Effects of Baicalein in Parkinson’s Disease

Baicalein may exhibit multi-target neuroprotective activity in PD by modulating integrity and oxidative stress–associated signaling pathways, and convergence of computational and in vitro findings supports its role in restoring neuronal redox balance and enhancing cellular resilience.

Ashitha Joseph, Anilkumar S. Kusnoor, Jyoti Talageri et al. · 0 citations
Open access Sep 2026

Comparative Network Pharmacology and Molecular Docking Analysis of Ursodeoxycholic Acid and Tauroursodeoxycholic Acid in Alzheimer’s Disease-Associated Molecular Networks

Results from approaches examining systems and structure both indicate that ursodeoxycholic acid and tauroursodeoxycholic acid show profiles of action that work together, but they should not be interpreted as direct evidence of therapeutic efficacy in Alzheimer’s disease.

Bo Zhou, Yu Zhong, Xin Meng et al. · 0 citations
Sep 2026

Uncovering the mechanism of gastrodin in treating Alzheimer's disease through bioinformatics, machine learning, and virtual gene knockout technology.

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline. Gastrodin is a natural compound with neuroprotective activity; however, the precise molecular mechanisms underlying its therapeutic effects on human AD remain unclear. This study employed bioinformatics approaches t...

Zi-Neng Zhou · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.